Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Trial of Microplasmin Intravitreal Injection for Non-Surgical Treatment of Focal Vitreomacular Adhesion. The MIVI-TRUST (TG-MV-007) Trial.

ClinicalTrials.gov ID: NCT00798317

Public ClinicalTrials.gov record NCT00798317. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 7:01 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Placebo Controlled, Double-masked, Multicenter Trial of Microplasmin Intravitreal Injection for Non-surgical Treatment of Focal Vitreomacular Adhesion.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This trial will evaluate the safety and efficacy of microplasmin, administered as an intravitreal injection, in subjects with focal vitreomacular adhesion. In previously performed clinical trials, some patients treated with intravitreal microplasmin have had resolution of their underlying condition, including macular hole closure, without need for vitrectomy. This clinical trial is justified because the sponsor believes the potential benefits outweigh the potential risks.

Study identification

NCT ID
NCT00798317
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
ThromboGenics
Industry
Enrollment
326 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2008 (Type not available)
Primary completion
Jun 2010 (Actual)
Completion
Jul 2010 (Actual)
Last update posted
Dec 17, 2014

2008 – 2010

United States locations

U.S. sites
20
U.S. states
13
U.S. cities
20
Facility City State ZIP Site status
Retinal Diagnostic Center Campbell California 95008 —
West Coast Retina Group, Inc San Francisco California 94107 —
California Retina Consultants Santa Barbara California 93103 —
Medeye Miami Florida 33143 —
Retina Specialists Pensacola Florida 32503 —
Paducah Retinal Center Paducah Kentucky 42001 —
Tufts Medical Center Boston Massachusetts 02111 —
Vision Research Center at Truman Medical Center Kansas City Missouri 64108 —
Deleware Valley Retina Associates Lawrenceville New Jersey 08648 —
Capital Region Retina Albany New York 12206 —
Southeast Clinical Research Assoicates, PA Charlotte North Carolina 28210 —
Dean A McGee Eye Institute Oklahoma City Oklahoma 73104 —
Scheie Eye Institute, Penn Eye Care Philadelphia Pennsylvania 19104 —
Black Hils regional Eye Institute Rapid City South Dakota 57701 —
Texas Retina Associates Arlington Texas 76012 —
Retina Research Center Austin Texas 78705 —
Retina Consultants Fort Worth Texas 76104 —
Medical Center Ophthalmology Assoc. San Antonio Texas 78240 —
Eye Care Associates Tyler Texas 75701 —
Vitreoretinal Associates Seattle Washington 98104 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 28 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00798317, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 17, 2014 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00798317 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →